Millions of people fall ill every year due to influenza or the common flu. But in February 2026, bio-tech company ‘Centivax’ began human trials of its ‘Universal Flu Vaccine’. The April 2026 report shows that this vaccine works on a part of the virus that never changes.
Investigation: How are these vaccines different from regular ones? Current flu vaccines have to be changed every year because the virus changes its form.
But this new vaccine from 2026 is expected to provide lifelong protection with a single dose. The World Health Organization (WHO) thinks that if it succeeds, it can save over 6 million lives by 2050.
Economic impact: The arrival of this vaccine will bring major changes to the global healthcare sector. Many developing countries are applying to become manufacturing partners for this vaccine by 2026
